Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Brain Neoplasms 9Sarcoma 7Glioma 6Meningioma 5Lung Neoplasms 5Esophageal Neoplasms 5Pancreatic Neoplasms 4Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Rhabdomyosarcoma 3Radiation Injuries 3Glioblastoma 3Chondrosarcoma 3Uterine Cervical Neoplasms 2Solid Tumor 2Pituitary Neoplasms 2Pinealoma 2Osteosarcoma 2Oligodendroglioma 2Nerve Sheath Neoplasms 2Nasopharyngeal Carcinoma 2Liver Neoplasms 2Hodgkin Disease 2Head and Neck Neoplasms 2Ependymoma 2Craniopharyngioma 2Chordoma 2Cholangiocarcinoma 2

Interventions

Magnetic Resonance Spectroscopy 5luprolide acetate gel depot 3Radiotherapy 3Radiosurgery 3Radiation 3Leuprolide 3Goserelin 3relugolix 2gallium 68 PSMA-11 2enzalutamide 2acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2Triptorelin Pamoate 2radium Ra 223 dichloride 1niraparib 1histrelin 1fluciclovine F-18 1flibanserin 1entinostat 1darolutamide 1bicalutamide 1atezolizumab 1apalutamide 1abiraterone 1X-Rays 1Watchful Waiting 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Specimen Handling 1Salicylic Acid 1Receptors, Bombesin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Prostate Adenocarcinoma × Proton Therapy × Clear all
NCT01352429 2025-07-17

Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer

Abramson Cancer Center at Penn Medicine

Active not recruiting
303 enrolled
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡